Treatments | Application (AVG) | N | P | K | Ca | Mg | Na |
Control | B | 30.89 ± 1.89 c | 24.71 ± 1.99 c | 46.50 ± 6.77 e | 51.79 ± 3.54 d | 4.45 ± 0.46 d | 5.90 ± 0.86 e |
B + F | |||||||
CF | B | 325.52 ± 12.42 a | 138.58 ± 11.73 a | 321.02 ± 15.61 d | 227.00 ± 27.20 b | 14.56 ± 1.38 ab | 74.51 ± 10.35 a |
B + F | |||||||
SLF1 | B | 248.85 ± 13.35 b | 108.82 ± 8.99 b | 394.52 ± 28.72 c | 180.83 ± 15.55 c | 10.87 ± 1.36 c | 23.68 ± 4.66 d |
B + F | |||||||
SLF2 | B | 317.84 ± 12.25 a | 123.11 ± 7.83 ab | 425.96 ± 10.13 ab | 233.93 ± 23.79 ab | 15.73 ± 2.31 a | 59.03 ± 7.95 b |
B + F | |||||||
SLF3 | B | 279.14 ± 28.31 b | 126.99 ± 8.80 a | 437.28 ± 9.21 a | 207.98 ± 13.52 bc | 12.40 ± 0.66 bc | 20.20 ± 5.98 d |
B + F | |||||||
SLF4 | B | 325.78 ± 22.03 a | 132.83 ± 9.44 a | 401.55 ± 14.49 bc | 265.45 ± 17.47 a | 17.17 ± 1.01 a | 39.97 ± 7.67 c |
B + F | |||||||
Source of variance | |||||||
Treatments | 26.66** | 17.53** | 33.24** | 35.85** | 2.46** | 12.88** | |
Application method | ns | ns | ns | ns | 0.95* | ns | |
Interaction (T × A) | ns | ns | ns | ns | ns | ns | |
CV% | 7.3 | 8.93 | 5.47 | 10.25 | 10.92 | 19.64 |